May Measurement Month 2019: The Global Blood Pressure Screening Campaign of the International Society of Hypertension

Thomas Beaney*, Aletta E Schutte, George S Stergiou, Claudio Borghi, Dylan Burger, Fadi J Charchar, Suzie Cro, Alejandro Bimbo Diaz, Albertino Damasceno, Walter G Espeche, Arun Pulikkottil Jose, Nadia A Khan, Yoshihiro Kokubo, Anuj Maheshwari, Marcos J Marin, Arun More, Dinesh Neupane, Peter M Nilsson, Mansi Patil, Dorairaj PrabhakaranAgustin Ramirez, Pablo D Rodriguez, Markus P Schlaich, Ulrike Muscha Steckelings, Maciej Tomaszewski, Thomas Unger, Richard D Wainford, Ji-Guang Wang, Bryan Williams, Neil R Poulter*

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

11 Downloads (Pure)


Elevated blood pressure remains the single biggest risk factor contributing to the global burden of disease and mortality. May Measurement Month is an annual global screening campaign aiming to improve awareness of blood pressure at the individual and population level. Adults ({greater than or equal to}18 years) recruited through opportunistic sampling were screened at sites in 92 countries during May 2019. Ideally three blood pressure readings were measured for each participant, and data on lifestyle factors and co-morbidities were collected. Hypertension was defined as a systolic BP {greater than or equal to} 140 mmHg, and/or a diastolic BP {greater than or equal to} 90 mmHg (mean of the second and third readings) or taking antihypertensive medication. When necessary, multiple imputation was used to estimate participants' mean blood pressure. Mixed-effects models were used to evaluate associations between blood pressure and participant characteristics. Of 1,508,130 screenees 482,273 (32.0%) had never had a blood pressure measurement before and 513,337 (34.0%) had hypertension, of whom 58.7% were aware and 54.7% were on antihypertensive medication. Of those on medication, 57.8% were controlled to <140/90 mmHg, and 28.9% to <130/80mmHg. Of all those with hypertension, 31.7% were controlled to <140/90mmHg and 350,825 (23.3%) participants had untreated, or inadequately treated hypertension. Of those taking antihypertensive medication, half were taking only a single drug and 25% reported using aspirin inappropriately. This survey is the largest ever synchronised and standardised contemporary compilation of global blood pressure data. This campaign is needed as a temporary substitute for systematic blood pressure screening in many countries worldwide.

TidsskriftHypertension (Dallas, Tex. : 1979)
Udgave nummer2
Sider (fra-til)333-341
StatusUdgivet - aug. 2020

Fingeraftryk Dyk ned i forskningsemnerne om 'May Measurement Month 2019: The Global Blood Pressure Screening Campaign of the International Society of Hypertension'. Sammen danner de et unikt fingeraftryk.

  • Citationsformater

    Beaney, T., Schutte, A. E., Stergiou, G. S., Borghi, C., Burger, D., Charchar, F. J., Cro, S., Diaz, A. B., Damasceno, A., Espeche, W. G., Jose, A. P., Khan, N. A., Kokubo, Y., Maheshwari, A., Marin, M. J., More, A., Neupane, D., Nilsson, P. M., Patil, M., ... Poulter, N. R. (2020). May Measurement Month 2019: The Global Blood Pressure Screening Campaign of the International Society of Hypertension. Hypertension (Dallas, Tex. : 1979), 76(2), 333-341.